Lantern Pharma Ownership | Who Owns Lantern Pharma?


OverviewFinancialsChartTranscripts

Lantern Pharma Ownership Summary


Lantern Pharma is owned by 23.00% institutional investors, 14.72% insiders, and 62.28% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 11.22% of LTRN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.37% of its assets in Lantern Pharma shares.

LTRN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLantern Pharma23.00%14.72%62.28%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bios capital management, lp1.21M11.22%$3.85M
Vanguard group363.72K3.38%$1.16M
Cm management200.00K1.86%$638.00K
Renaissance87.30K0.81%$278.49K
Geode capital management86.97K0.81%$277.52K
Newedge advisors68.36K0.64%$218.07K
Voss capital50.00K0.46%$159.50K
Blackrock funding, inc. /de40.60K0.38%$129.50K
Blackrock39.84K0.37%$186.06K
Redmond asset management37.27K0.35%$118.89K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bios capital management, lp1.21M4.02%$3.85M
Cm management200.00K0.57%$638.00K
Redmond asset management37.27K0.03%$118.89K
Westside investment management30.65K0.02%$97.78K
Voss capital50.00K0.01%$159.50K
Sigma planning28.45K0.00%$90.76K
Richards, merrill & peterson975.000.00%$3.11K
Newedge advisors68.36K0.00%$218.07K
Perigon wealth management14.60K0.00%$52.56K
Horizon kinetics asset management28.79K0.00%$91.84K

Top Buyers

HolderShares% AssetsChange
Bios capital management, lp1.21M4.02%1.21M
Voss capital50.00K0.01%50.00K
Blackrock39.84K-20.18K
Cm management200.00K0.57%15.00K
Millennium management10.13K-10.13K

Top Sellers

HolderShares% AssetsChange
Newedge advisors68.36K0.00%-68.98K
Davenport25.81K0.00%-28.00K
Pathway financial advisors---25.00K
Jane street group---24.87K
Two sigma investments, lp16.55K0.00%-17.80K

New Positions

HolderShares% AssetsChangeValue
Bios capital management, lp1.21M4.02%1.21M$3.85M
Voss capital50.00K0.01%50.00K$159.50K
Millennium management10.13K-10.13K$47.33K
Royal bank of canada1.42K-1.42K$7.00K
Richards, merrill & peterson975.000.00%975.00$3.11K

Sold Out

HolderChange
Qube research-2.00
Federated hermes-74.00
Cypress capital-200.00
Stone house investment management-200.00
Pnc financial services group-250.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202432-3.03%2,475,91385.34%2314.93%147.69%1025.00%
Sep 30, 202433-19.51%1,335,8713.88%128.66%13-27.78%8-42.86%
Jun 30, 20244110.81%1,286,03616.02%1111.45%18-5.26%1440.00%
Mar 31, 20243723.33%1,108,4291.09%1010.02%19137.50%10-16.67%
Dec 31, 20233011.11%1,096,470-3.68%109.19%8-12100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv256.11K2.37%-
Vanguard US Total Market Shares ETF256.11K2.37%-
Vanguard Institutional Extnd Mkt Idx Tr99.27K0.92%-
Fidelity Extended Market Index44.47K0.41%-283.00
Horizon Kinetics Medical ETF28.79K0.27%-
DFA US Targeted Value I21.32K0.20%-
iShares Micro-Cap ETF16.67K0.15%-
BlackRock Extended Equity Market K15.56K0.14%-7.00
Fidelity Total Market Index15.40K0.14%-
Extended Equity Market Fund K15.40K0.14%47.00

Recent Insider Transactions


DateNameRoleActivityValue
May 24, 2024Kreis Leslie W.-Sell$87.91K
May 23, 2024Kreis Leslie W.-Sell$13.29K
May 24, 2024Kreis Leslie W.-Sell$26.92K
May 23, 2024Kreis Leslie W.-Sell$5.81K
May 23, 2024Kreis Leslie W.-Sell$43.40K

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2-12
2024 Q1-24
2023 Q4-4
2022 Q4-10

LTRN Ownership FAQ


Who Owns Lantern Pharma?

Lantern Pharma shareholders are primarily institutional investors at 23.00%, followed by 14.72% insiders and 62.28% retail investors. The average institutional ownership in Lantern Pharma's industry, Biotech Stocks , is 68.48%, which Lantern Pharma falls below.

Who owns the most shares of Lantern Pharma?

Lantern Pharma’s largest shareholders are Bios capital management, lp (1.21M shares, 11.22%), Vanguard group (363.72K shares, 3.38%), and Cm management (200K shares, 1.86%). Together, they hold 16.46% of Lantern Pharma’s total shares outstanding.

Does Blackrock own Lantern Pharma?

Yes, BlackRock owns 0.37% of Lantern Pharma, totaling 39.84K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 186.06K$. In the last quarter, BlackRock increased its holdings by 20.18K shares, a 102.66% change.

Who is Lantern Pharma’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Lantern Pharma’s biggest shareholder by percentage of total assets invested, with 4.02% of its assets in 1.21M Lantern Pharma shares, valued at 3.85M$.

Who is the top mutual fund holder of Lantern Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lantern Pharma shares, with 2.37% of its total shares outstanding invested in 256.11K Lantern Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools